UMAC dropped -8.96% during regular trading hours, sliding from its $14.62 prior close to roughly $13.31 intraday. No verified news or fundamental catalyst found. With Q3 results due November 5, the decline likely reflects continued profit-taking in a high-beta, speculative drone name—consistent with its roughly ±4.6% average daily move, with seven of the past 60 sessions swinging more than today.

ALAB dropped from a prior close of $233.62 to roughly $220.60, a -5.57% decline, during regular trading hours. The slide came after its Q3 beat — record revenue of $584.9M (+154% YoY) and EPS of $1.32 versus $1.19 — as analysts cut price targets (Needham to $300, Jefferies to $350, Evercore to $311), citing AI-sector valuation compression and a possible H1 2027 growth pause.

Mercury General (MCY) dropped during regular trading, falling from a $102.71 previous close to $95.13, a decline of -7.38%. The selloff follows Q3 results reported after Tuesday's close: a GAAP net loss of $0.25/share versus a $5.06 year-ago profit, driven by $262M in realized investment losses tied to rising interest rates, alongside a revenue miss.

GSM fell -5.70% during regular trading, sliding from its $3.86 prior close to $3.64 and extending the after-hours decline that began after Tuesday's earnings release. The drop followed a Q3 miss: adjusted EPS of -$0.06 versus -$0.03 expected, revenue of $369.8M versus a $382.8M consensus, and adjusted EBITDA swinging to -$2.4M from +$13.1M.

VET slid -8.8% during regular trading hours, falling from a $12.38 prior close to $11.29. The drop followed Q3 2026 results, where Vermilion swung to a $34.6M net loss on roughly $245M in unrealized derivative losses, with GAAP EPS of -$0.23 missing estimates widely.

WYHG dropped during regular trading hours, sliding from a previous close of $3.19 to $2.98, a decline of -6.58%. No verified news or fundamental catalyst found. The pullback likely reflects profit-taking after the prior session's +16.85% surge on heavy volume, consistent with this Chinese micro-cap ADR's habit of double-digit daily swings.

SM Energy shares dropped -7.55% to $33.90 from the prior close of $36.67 during regular trading hours, extending an after-hours decline. The selloff followed Q3 2026 earnings reported after Monday's close, which beat on revenue but included sharply lower GAAP profit and a ~1% cut to full-year oil production guidance.

YDES climbed +1.56% during regular trading hours, rising from a previous close of $6.40 to $6.50. No verified news or fundamental catalyst found. The move is consistent with routine speculative trading in this micro-cap biotech, which habitually swings by double-digit percentages; today's gain is far smaller than its typical daily move.

BTDR shares eased to $6.74 from a prior close of $6.92, a decline of -2.60% during regular market hours. No verified news or fundamental catalyst found. The pullback is consistent with profit-taking after Tuesday's +12.16% jump and sits within the stock's typical daily move of roughly ±5%.

Shares of Aspen Neuroscience slipped roughly -2.60% in premarket trading, easing from Tuesday's $12.29 close to about $11.97 and extending a slide in the newly listed biotech. No verified news or fundamental catalyst found. The decline is consistent with continued post-IPO selling pressure in a thinly floated stock that has closed lower every session since pricing at $15 on October 30, a pattern typical of a fresh listing trading below its offer price.

LYNX rose +1.56% during the regular session, closing at $11.71 versus a $11.53 prior close — a modest gain within its normal trading range. No verified news or fundamental catalyst found. The move is smaller than the stock's roughly 3% average daily swing and is consistent with routine positioning ahead of Lyntris' Q3 FY2026 earnings due after the close on Nov 4.

RZAI tumbled from a prior close of $5.76 to $3.87, a -32.81% drop, during regular trading on November 3. No verified news or fundamental catalyst found. The only fresh release — a Nov 2 non-binding BKB Energy data-center MOA — was upbeat, so the move is consistent with profit-taking and dilution concerns in a thinly traded, recently direct-listed micro-cap that had already shed roughly 80% over the prior month, with its preferred-share conversion floor resetting from $4.00 toward $1.00.

AQST is trading higher during regular market hours on Wednesday, rising +1.29% (+$0.05) from its prior close of $3.88 to $3.93. The move follows the company's Q3 2026 report released after the Nov 3 close, which missed on EPS (-$0.13 vs -$0.11 est.) and revenue ($7.6M vs $11.0M est.), though unchanged full-year guidance and the March 16, 2027 Anaphylm PDUFA date cushioned the stock, reinforced by this morning's earnings call.

EROC shares fell -14.06% to $7.70 during regular trading hours, down from the previous session's close of $8.96. No verified news or fundamental catalyst found. The decline likely reflects profit-taking after the prior session's +13.42% surge, consistent with speculative, high-volatility trading in this heavily shorted recent IPO.

Galaxy Digital (GLXY) fell from a previous close of $16.83 to $15.45, down -8.20%, during regular market hours. Morgan Stanley flagged Texas data-center risk for Galaxy and peers after Democrat Gina Hinojosa's governor win, citing possible delays at the Helios II project, while crypto stocks sold off broadly.

DDS slid -5.96% on Tuesday, falling from a prior close of $646.16 to $607.62 during regular trading hours. The decline followed UBS reiterating a Sell rating with a $465 price target, citing a customer-loyalty survey that showed continued shopper attrition, weaker brand relevance, and negative price perception.

KMT dropped from its prior close of $30.53 to $26.76, a -12.35% decline during regular trading hours. Fiscal Q1 2027 results, released before the open, missed on revenue ($768.2M vs. ~$771M consensus) and underwhelmed on next-quarter guidance, overshadowing a record $3.48 EPS that beat the $2.66 estimate.

EMCOR Group (EME) fell sharply during regular trading hours, sliding from a prior close of $707.43 to roughly $641.82, a drop of -9.27%. The decline reflects a broad rotation out of richly valued data-center and AI-infrastructure engineering names, with recent analyst price-target cuts (UBS to $925, Oppenheimer to $1,000) flagging "AI unknown" fears rather than any company-specific bad news.

CIX shares climbed to $37.51 from a prior close of $35.36, a +6.08% gain during regular market hours. The rise came ahead of CompX's third-quarter 2026 earnings report, scheduled for release after today's close, as traders positioned for the results.

NSP advanced during regular market hours, climbing from a previous close of $49.98 to $52.61, a gain of +5.26% (+$2.63). No verified news or fundamental catalyst found; the move looks like a rebound amid continued post-earnings volatility, consistent with the stock's recent pattern of ±5% daily swings.